-

AHF Slams Express Scripts Over Lawsuit to Retract Critical PBM Report

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the many healthcare providers outraged over Express Scripts’ meritless lawsuit designed to deflect attention away from PBM abuses that harm patient care. It is laughable that ESI would demand a retraction of an agency report released by the Federal Trade Commission (FTC) that highlights the role pharmacy benefit managers (PBMs) play in the high cost of prescription drugs.

The lawsuit comes as the FTC readies litigation against the three largest PBMs for a host of anticompetitive practices that distort the prescription drug market in favor of drug middlemen at the expense of independent pharmacies and the everyday Americans they serve. The timing is anything but a coincidence.

The three largest PBMs – Express Scripts, CVS Caremark, and OptumRx – control approximately 80% of the prescription drug market. With such power, PBMs exploit their privileged position in the prescription drug supply chain, demanding higher rebates from pharmaceutical companies in exchange for access to formularies – the lists PBMs develop for insurers to administer prescription drug plans.

AHF knows all too well how the big three PBM/health insurance mega firms treat independent pharmacies. By design, PBMs force AHF patients out of our custom HIV-care model and into mandatory mail-order delivery, undermining health outcomes. Express Scripts and the other PBM conglomerates provide no value to our patients but want to dictate how people living with HIV access care and therapeutics.

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.1 million individuals across 47 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.

Contacts

Ged Kenslea, AHF Senior Communications Dir.
gedk@aidshealth.org
(323) 791-5526

AIDS Healthcare Foundation


Release Summary
AHF Slams Express Scripts Over Lawsuit to Retract Critical PBM Report
Release Versions

Contacts

Ged Kenslea, AHF Senior Communications Dir.
gedk@aidshealth.org
(323) 791-5526

More News From AIDS Healthcare Foundation

Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary

MEXICO CITY--(BUSINESS WIRE)--The Latin American Technical Working Group, composed of former health ministers from the region, public health experts, epidemiologists, academics, and civil society representatives, published a new comment in The Lancet arguing that Latin America urgently needs a regional rapid-response platform to prevent, prepare for, and respond to infectious threats. Read the full text in The Lancet here. The comment, written collectively by the Technical Working Group, takes...

AHF Welcomes Lula–Tedros Call for Equity in Pandemic Agreement, Warns against Rushing Empty Deal

MIAMI, GENEVA & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute welcome the open letter issued by President Luiz Inácio Lula da Silva of Brazil and World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus on the occasion of the G7 Summit, calling on the leaders of the G7, G20, BRICS, and all nations to finish the Pathogen Access and Benefit-Sharing (PABS) annex of the WHO Pandemic Agreement. AHF particularly commends t...

AHF: Ebola Outbreak Exposes Need for Stronger Investment in Preparedness

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) calls for stronger investments in Ebola preparedness and response as the current outbreak in the Democratic Republic of the Congo and Uganda underscores the continued threat posed by the deadly disease and the urgent need to strengthen public health systems across Africa. The outbreak is caused by the Bundibugyo virus strain, for which there is currently no approved vaccine or specific treatment. While progress has been made in...
Back to Newsroom